Famotidine

Note: This product is not licensed in Australia at the time of publication. The information in this monograph applies to the specified brand, formulation and strength only.

Trade name

Famotidine (Mylan), Famotidine USP

Presentation and preparation

10 mg/mL (volume: 2 mL, 4 mL, 20 mL)

IV administration

Dilute to 4 mg/mL or weaker and give over at least 2 minutes at a maximum rate of 10 mg/minute.

For intravenous infusion: Dilute to 0.2 mg/mL and infuse over 15 – 30 minutes.

Other routes of administration

IM: Not recommended

SC: Not recommended

Compatible IV fluids

Glucose 5%

Glucose 10%

Hartmann’s

Sodium chloride 0.9%

Y-site only and famotidine diluted in Glucose 5% or Sodium chloride 0.9%:

Potassium chloride 20 mmol/L

 Y-site only and famotidine 2 mg/mL or weaker diluted in Glucose 10% or Hartmann’s:

Potassium chloride 20 mmol/L

Additional information

Use with caution in neonates; contains benzyl alcohol which has been linked with ‘gasping syndrome’.

Refrigerate, do not freeze.

Protect from light during storage.